Litcius/Paper detail

Repurposing drugs as COVID-19 therapies: A toxicity evaluation

Deborah K. Ngan, Tuan Xu, Menghang Xia, Wei Zheng, Ruili Huang

2022Drug Discovery Today22 citationsDOIOpen Access PDF

Topics & Concepts

hERGDrug repositioningPhospholipidosisDrugPharmacologyRepurposingCoronavirus disease 2019 (COVID-19)CoronavirusDrug discoveryToxicitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineChemistryBioinformaticsBiologyPotassium channelInternal medicineInfectious disease (medical specialty)DiseaseBiochemistryEcologyMembranePhospholipidSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesMosquito-borne diseases and control
Repurposing drugs as COVID-19 therapies: A toxicity evaluation | Litcius